<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02770924</url>
  </required_header>
  <id_info>
    <org_study_id>CAAE 49921915.1.0000.5505</org_study_id>
    <nct_id>NCT02770924</nct_id>
  </id_info>
  <brief_title>Clinical Outcomes After Bilateral Implantation of ZEISS AT LISA TRI AND TRI TORIC IOL</brief_title>
  <official_title>Clinical Outcomes After Bilateral Implantation of ZEISS AT LISA TRI AND TRI TORIC IOL</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federal University of São Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Instituto Paulista de Estudos e Pesquisa em Oftalmologia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Eye Clinic Day Hospital, São Paulo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Federal University of São Paulo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate the visual function of patients with bilateral&#xD;
      implantation of the IOL trifocal ZEISS AT LISA TRI AND TRI TORIC by means of visual acuity&#xD;
      tests with and without optical correction, sensitivity curve contrast, defocus curve and&#xD;
      quality questionnaire visual function (VFQ-25).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Twenty patients (40 eyes) diagnosed with cataracts and cataract surgery indication will be&#xD;
      selected to participate in this study. The surgery will be performed by the same surgeon with&#xD;
      2 week interval between surgery the first and second eye. After approval of the research&#xD;
      project by the Research Ethics Committee all patients should understand and sign the Informed&#xD;
      Consent and Informed (IC) before surgery.&#xD;
&#xD;
      All patients will be operated by conventional phacoemulsification with implantation of&#xD;
      intraocular lens provided by the manufacturer.&#xD;
&#xD;
      Patients will have five study visits, including the preoperative visit, operative visit four&#xD;
      postoperative visits.&#xD;
&#xD;
      All patients will be submitted to the following routine assessments preoperatively and&#xD;
      demographic patient information will be recorded and a detailed medical history will be&#xD;
      obtained.&#xD;
&#xD;
        -  VFQ-25 Questionnaire&#xD;
&#xD;
        -  Identification of the dominant eye;&#xD;
&#xD;
        -  Visual acuity&#xD;
&#xD;
        -  Refraction&#xD;
&#xD;
        -  Slit lamp examination&#xD;
&#xD;
        -  Tonometry&#xD;
&#xD;
        -  Self-keratometry;&#xD;
&#xD;
        -  Corneal topography;&#xD;
&#xD;
        -  Microscopy speculate&#xD;
&#xD;
        -  Fundus examination.&#xD;
&#xD;
      In addition, all routine preoperative measures will be performed. lens power calculations&#xD;
      should be performed on both eyes to ensure qualification (lens power within the diopter range&#xD;
      (D) available) and prepare for surgery (getting the lens). The emmetropia (± 0.5 D) should be&#xD;
      the target of patients.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2016</start_date>
  <completion_date type="Actual">September 13, 2017</completion_date>
  <primary_completion_date type="Actual">July 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Binocular visual acuity for far, intermediate and near distance</measure>
    <time_frame>Changes from Pre-Op to Month 3</time_frame>
    <description>Visual acuity measurements</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Defocus Curve</measure>
    <time_frame>Month 3</time_frame>
    <description>Test of Defocus Curve</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Contrast Sensitivity</measure>
    <time_frame>Changes from Pre-Op and Month 3</time_frame>
    <description>Compare scores of contrast sensitivity pre-op and post-op</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>VFQ-25 Questionnaire</measure>
    <time_frame>Changes from Pre-Op and Month 3</time_frame>
    <description>Compare answers between pre-op and post-op</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>AT LISA TRI TORIC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All patients will be undergo to phacoemulsification with IOL implantation bilateral</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AT LISA TRI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All patients will be undergo to phacoemulsification with IOL implantation bilateral</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AT LISA TRI TORIC</intervention_name>
    <description>phacoemulsification with IOL implantation</description>
    <arm_group_label>AT LISA TRI TORIC</arm_group_label>
    <other_name>ZEISS AT LISA TRI TORIC</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AT LISA TRI</intervention_name>
    <description>phacoemulsification with IOL implantation</description>
    <arm_group_label>AT LISA TRI</arm_group_label>
    <other_name>ZEISS AT LISA TRI</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients older than 50 years&#xD;
&#xD;
          -  Cataract diagnosis indicating surgery in both eyes&#xD;
&#xD;
          -  Corneal astigmatism to 12D (AT lisa tri toric)&#xD;
&#xD;
          -  Corneal astigmatism less than 0,75D (AT lisa tri)&#xD;
&#xD;
          -  Ability to provide consent and clarification for study participation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Significant irregular corneal astigmatism as shown by Corneal topography;&#xD;
&#xD;
          -  Corneal astigmatism up 12D&#xD;
&#xD;
          -  Patients diagnosed with severe visual degenerative disorders (e.g. macular&#xD;
             degeneration or other disorder of the retina)&#xD;
&#xD;
          -  Previous corneal surgery;&#xD;
&#xD;
          -  Amblyopia&#xD;
&#xD;
          -  Planning for multiple procedures, including IRL, LASIK, etc. during surgery or during&#xD;
             the study&#xD;
&#xD;
          -  Endothelial dystrophy clinically significant cornea (eg, Fuchs dystrophy)&#xD;
&#xD;
          -  Corneal disease activity (eg, herpes simplex, herpes zoster, etc.)&#xD;
&#xD;
          -  Severe diabetic retinopathy&#xD;
&#xD;
          -  Retinal detachment&#xD;
&#xD;
          -  Glaucoma&#xD;
&#xD;
          -  Patients presenting illness or acute conditions or chronic severe that in the opinion&#xD;
             of the investigator, would increase the surgical risk or confound the research results&#xD;
&#xD;
          -  Any patient who is taking part in another study involving ocular surgery&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rubens Belfort, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>IPEPO Instituto Paulista de Estudos e Pesquisas em Oftalmologia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>IPEPO</name>
      <address>
        <city>São Paulo</city>
        <zip>04023062</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eye Clinic</name>
      <address>
        <city>São Paulo</city>
        <zip>04502-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <study_first_submitted>May 4, 2016</study_first_submitted>
  <study_first_submitted_qc>May 10, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 12, 2016</study_first_posted>
  <last_update_submitted>September 13, 2017</last_update_submitted>
  <last_update_submitted_qc>September 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federal University of São Paulo</investigator_affiliation>
    <investigator_full_name>Rubens Belfort Jr.</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>cataract</keyword>
  <keyword>phacoemulsification</keyword>
  <keyword>AT LISA TRI TORIC</keyword>
  <keyword>IOL</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>paper publication</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

